Literature for peptidase S01.140: chymase (Homo sapiens-type)

(References are filtered for relevance to Review. To remove the filter click here. See explanation.)

2023
1. Ferrario,C.M., Ahmad,S., Speth,R. and Dell'Italia,L.J.
   Is chymase 1 a therapeutic target in cardiovascular disease?
   Expert Opin Ther Targets27, 645-656. PubMed  Europe PubMed DOI  V
2020
2. Vibhushan,S., Bratti,M., Montero-Hernandez,J.E., El Ghoneimi,A., Benhamou,M., Charles,N., Daugas,E. and Blank,U.
   Mast Cell Chymase and Kidney Disease
   Int J Mol Sci22, PubMed  Europe PubMed DOI  V
2018
3. Dell'Italia,L.J., Collawn,J.F. and Ferrario,C.M.
   Multifunctional role of chymase in acute and chronic tissue injury and remodeling
   Circ Res122, 319-336. PubMed  Europe PubMed DOI  V
2012
4. Heuston,S. and Hyland,N.
   Chymase inhibition as a pharmacological target: a role in inflammatory and functional gastrointestinal disorders?
   Br J Pharmacol167, 732-740. PubMed  Europe PubMed DOI  V
2010
5. Pejler,G., Ronnberg,E., Waern,I. and Wernersson,S.
   Mast cell proteases: multifaceted regulators of inflammatory disease
   Blood115, 4981-4990. PubMed  Europe PubMed DOI  V
2005
6. Leckie,B.J.
   Targeting the renin-angiotensin system: what's new?
   Curr Med Chem Cardiovasc Hematol Agents3, 23-32. PubMed  Europe PubMed DOI  V
2004
7. Caughey,G.H.
   Chymases
   [ISSN:0-12-079610-4]2, 1531-1535.  V